Pharmacodynamics and pharmacokinetics of long-acting insulin analogues detemir and glargine after 7 days of use and after its first administration in subjects with type 1 diabetes

被引：0
|
作者：
Bock, G. [1 ]
Wutte, A. [1 ]
Koehler, G. [1 ]
Korsatko, S. [1 ]
Semlitsch, B. [1 ]
Pieber, T. R. [1 ]
机构：
[1] Med Univ Graz, Graz, Austria
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
968
引用
收藏
页码：S390 / S390
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes
    Porcellati, Francesca
    Rossetti, Paolo
    Ricci, Natalia Busciantella
    Pampanelli, Simone
    Torlone, Elisabetta
    Campos, Susana Hernandez
    Andreoli, Anna Marinelli
    Bolli, Geremia B.
    Fanelli, Carmine G.
    [J]. DIABETES CARE, 2007, 30 (05) : 1261 - 1263
  • [2] The effect of long-acting insulin analogues, glargine or detemir, in Type 2 diabetes
    Dissanayake, S.
    Balakrisna-Rao, P.
    Ahmed, A. B.
    [J]. DIABETIC MEDICINE, 2007, 24 : 75 - 75
  • [3] Pharmacokinetics and -dynamics of therapeutic doses of the "long-acting" insulin analogues glargine and detemir at steady-state in type 1 diabetes mellitus
    Porcellati, Francesca
    Rossetti, Paolo
    Busciantella, Natalia
    Marzotti, Stefania
    Lucidi, Paola
    Fanelli, Carmine G.
    Owens, David R.
    Bolli, Geremia B.
    [J]. DIABETES, 2006, 55 : A130 - A130
  • [4] Pharmacokinetics and -dynamics of therapeutic doses of the "long-acting" insulin analogues glargine and detemir at steady-state in type 1 diabetes mellitus
    Porcellati, F.
    Rossetti, P.
    Busciantella, N. Ricci
    Marzotti, S.
    Lucidi, P.
    Fanelli, C. G.
    Owens, D. R.
    Luzio, S. D.
    Bolli, G. B.
    [J]. DIABETOLOGIA, 2006, 49 : 622 - 623
  • [5] Pharmacodynamics of the long-acting insulin analogues detemir and glargine following single-doses and under steady-state conditions in patients with type 1 diabetes
    Koehler, G.
    Treiber, G.
    Wutte, A.
    Korsatko, S.
    Mader, J. K.
    Semlitsch, B.
    Pieber, T. R.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (01): : 57 - 62
  • [6] Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: comparison of glycaemic control and pregnancy outcome
    Callesen, Nicoline F.
    Damm, Julie
    Mathiesen, Jonathan M.
    Ringholm, Lene
    Damm, Peter
    Mathiesen, Elisabeth R.
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2013, 26 (06): : 588 - 592
  • [7] Economic evaluation of switching type-1 diabetes patients from long-acting insulin glargine in a basal/bolus regimen to long-acting insulin detemir in an Austrian setting
    Palmer, AJ
    Wittrup-Jensen, KU
    Hansen, JB
    Roze, S
    Valentine, WJ
    [J]. VALUE IN HEALTH, 2005, 8 (06) : A160 - A160
  • [8] Treatment of Type 1 and Type 2 Diabetes Mellitus with Insulin Detemir, a Long-Acting Insulin Analog
    Young, Jason R.
    McAdam-Marx, Carrie
    [J]. CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2010, 3 : 65 - 80
  • [9] Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes
    Schiavon, Michele
    Visentin, Roberto
    Giegerich, Clemens
    Klabunde, Thomas
    Cobelli, Claudio
    Dalla Man, Chiara
    [J]. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2020, 67 (02) : 624 - 631
  • [10] Insulin glargine - A review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus
    McKeage, K
    Goa, KL
    [J]. DRUGS, 2001, 61 (11) : 1599 - 1624
12345